News

Qilu ranked top 10 of the Chinese Pharmaceutical Industry in 4 consecutive times

ABOUT US

News

Qilu ranked top 10 of the Chinese Pharmaceutical Industry in 4 consecutive times

Release time：

2018-08-04

The 35th National Pharmaceutical Industry Summit was held in Shanghai on Aug.4^th, 2018, and the top 100 list of the Chinese pharmaceutical companies was released at this annual meeting. Qilu Pharmaceutical ranks No.8 as last year. Qilu Pharmaceutical first entered into the top 10 list in 2014 and remains on the top 10 list since then.

Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA

Qilu honored as the top 20 leading enterprise of internationalization

Related News

Qilu Pharmaceutical ranks No.3 in the list of "Top 100 Enterprises in Chinese Pharmaceutical industry”

2024-09-30

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”